The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
PDS Biotechnology Corporation(NASDAQ:PDSB)


PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, focuses on developing multifunctional cancer immunotherapies. Its lead product candidate is PDS0101 (HPV16), which is in Phase II clinical trial provides a first line treatment for the recurrent/metastatic head and neck cance...
Share this website to your friends
PDS Biotechnology Days Payable Outstanding ttm (DPO)
PDS Biotechnology Op Cashflow Per Share ttm
PDS Biotechnology Free Cashflow Per Share ttm
PDS Biotechnology Cash Per Share ttm
PDS Biotechnology (GAAP) P/E ratio ttm
PDS Biotechnology P/B ratio ttm
No extra charts and metrics for this ticker.